Claims Data Analysis of Dosing and Cost of TNF Antagonist
Higher drug costs may be attributable to either high initial doses or a dose increase.
Impact of Risk Evaluation and Mitigation Strategies in Oncology
December 22nd 2010The management of risk in medicine is emerging as a priority topic for numerous stakeholders, including patients, providers (physicians, other prescribers, and pharmacists), specialty pharmacies, industry, and government organizations.